Transfusion Medicine and Hemotherapy

ISSN: 1660-3796• JCR: TRANSFUS MED HEMOTHKarger PublishersSwitzerland
Visit Journal Homepage
1.9
2025 Impact Factor
2.6
5-Year Impact Factor
Q3
JCR Quartile
B4
CAS Block

Transfusion Medicine and Hemotherapy impact factor and JCR quartile

The 2025 impact factor for Transfusion Medicine and Hemotherapy is 1.9. The 5-year impact factor is 2.6. The journal is listed as JCR Q3 in the current Journal Metrics dataset.

Use this record to check the journal title, ISSN, JCR quartile, CAS block, publisher details, and similar journals before comparing publication venues.

If you searched for Transfusion Medicine and Hemotherapy impact factor 2025, compare this exact title record with the journal homepage and nearby journals in the same field. That helps avoid mixing this journal with a similarly named title, abbreviation, society series, or outdated metric snippet.

2025 impact factor and source check

This page is designed for exact-title searches such as Transfusion Medicine and Hemotherapy impact factor 2025. First confirm that the ISSN and title match this record before using the metric in a journal shortlist or submission decision.

For high-stakes submission decisions, verify the title against the publisher record at the journal homepage, Clarivate's Master Journal List or Journal Citation Reports if you have access, and the context in our methodology. Treat the 5-year impact factor, JCR quartile, article volume, and similar journals as supporting context rather than a single-number publication decision.

Journal Details

Total Articles
4,696
H-Index
71
Open Access
Yes
APC
$1,670 USD
Subject Areas
Economics and EconometricsAerospace EngineeringHematologyBiochemistryManagement of Technology and Innovation

Article Volume

2021
67
2022
72
2023
83
2024
59
2025
51
2026
17
Back to Search